Načítá se...

Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies

BACKGROUND: Pyoderma gangrenosum (PG) belongs to a group of neutrophilic dermatoses and is often associated with systemic disorders. The authors present a patient with a recalcitrant PG that did not respond to systemic standard therapies, and discuss further treatment options with impact on quality...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hinterberger, Louisa, Müller, Cornelia S. L., Vogt, Thomas, Pföhler, Claudia
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare Communications 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510423/
https://ncbi.nlm.nih.gov/pubmed/23205329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-012-0006-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!